Read + Share
Weng W, Meng T, Pu J, Ma L, et al. AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential
to Broaden Therapeutic Opportunities for HER3-expressing Tumors. Mol Cancer Ther 2023;22:1013-1027.
PMID: 37302522
|
 |
|
Weng W, Meng T, Pu J, Ma L, et al. AMT-562, a Novel HER3-targeting Antibody-Drug Conjugate, Demonstrates a Potential
to Broaden Therapeutic Opportunities for HER3-expressing Tumors. Mol Cancer Ther 2023;22:1013-1027.
PMID: 37302522
|
|
|
|